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Following linear accelerator commissioning, the qualified medical physicist is 
responsible for monitoring the machine’s ongoing performance, detecting and 
investigating any changes in beam properties, and assessing the impact of unsched-
uled repairs. In support of these responsibilities, the authors developed a method of 
using a 2D ionization chamber array to efficiently test and validate important linear 
accelerator photon beam properties. A team of three physicists identified critical 
properties of the accelerator and developed constancy tests that were sensitive to 
each of the properties. The result was a 14-field test plan. The test plan includes 
large and small fields at varying depths, a reduced SSD field at shallow depth for 
sensitivity to extra focal photon and electron components, and analysis of flatness, 
symmetry, dose, dose profiles, and dose ratios.  Constancy tests were repeated five 
times over a period of six weeks and used to set upper and lower investigation 
levels at ± 3 SDs. Deliberate variations in output, penumbra, and energy were 
tested to determine the suitability of the proposed method. Measurements were also 
performed on a similar, but distinct, machine to assess test sensitivity. The results 
demonstrated upper and lower investigation levels significantly smaller than the 
comparable TG-142 annual recommendations, with the exception of the surrogate 
used for output calibration, which still fell within the TG-142 monthly recom-
mendation. Subtle changes in output, beam energy, and penumbra were swiftly 
identified for further investigation. The test set identified the distinct nature of the 
second accelerator. The beam properties of two photon energies can be validated 
in approximately 1.5 hrs using this method. The test suite can be used to evaluate 
the impact of minor repairs, detect changes in machine performance over time, 
and supplement other machine quality assurance testing.
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I. INTRODUCTION
After a linear accelerator is commissioned and placed into service, the qualified medical 
physicist is responsible for monitoring the machine’s ongoing performance and assessing the 
impact of unscheduled repairs. This quality control (QC) testing is performed as a component 
of the overall quality assurance (QA) program.(1,2) QC testing sometimes includes a valida-
tion of the beam properties of the accelerator, which we can describe as the spatial, spectral, 
and dosimetric properties of the output radiation field under the range of expected operating 
conditions. This type of validation testing typically relies on a subset of the commissioning and 
acceptance procedure and requires the setup of a scanning water phantom. Facilities  routinely 
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perform this scanning as a component of their annual accelerator testing. Major repairs require 
a similar validation of the beam properties. Even for an experienced physicist, setup and use of 
the scanning water phantom, with subsequent data analysis, typically takes a full day. Minor 
repairs usually do not require this level of validation, but sometimes the extent of a repair is 
unknown or can be deceiving. Several components may be disassembled and reassembled 
before the offending one is identified and replaced. As a result, the true nature of the required 
testing can be uncertain. A contingency plan for a thorough and quick validation of machine 
beam properties is prudent. Consequently, the authors considered a method of using a 2D ioniza-
tion chamber array, the MatriXX Evolution from IBA Dosimetry (Bartlett, TN), to efficiently 
validate the constancy of beam properties following minor repairs. This method may also find 
use as a supplement to the annual machine performance evaluation, or as an “early warning 
system” for detecting drifts in performance.
 
II. MATERIALS AND METHODS
A.  Beam property tests
A Varian TrueBeam (Varian Medical Systems, Palo Alto, CA) operating at 6 MV was the platform 
used for developing a beam validation method. The mechanical properties of the machine, to 
include gantry and collimator angular position accuracy, jaw positions, field sizes, and MLC 
calibrations, are assumed to be validated by other, traditional methods prior to the validation 
of the beam properties. This approach is consistent with current practices for beam validation 
using a scanning water phantom.
In order to develop an appropriate beam property test suite, the authors considered a num-
ber of factors including conceptual sources of primary and extrafocal radiation, aspects of the 
control system, and the spectral properties of the fluence exiting the head of the machine.(3,4) 
Contributing components were further investigated in the literature, and the findings were used 
by the authors to generate a minimalist, consensus set of measurements sensitive to the major 
components. The suite of tests was designed to recognize changes in properties only and not 
measure absolute values for any parameter, such as focal spot size, penumbra, or energy. This 
afforded a great advantage in speed and efficiency but, in some cases, may preclude the later 
decoupling of the properties. The tests were initially designed to be applicable to any planar 
ionization chamber array. They rely strictly on a comparison of a measured value to a baseline 
average value generated using a series of reference measurements. A description of the design 
and purpose of each test field, with letter identifiers A through K, is listed below.
Test field A validates the output constancy of the linear accelerator using a simple measure-
ment of the central axis dose, or a dose surrogate, for a standard test field.
Test field B validates the primary focal spot size, shape, and location using the surrogate of 
penumbra.(5,6) Both the X and Y penumbra are evaluated.
Test field C validates the location of the primary focal spot using a test of output at a reduced 
source-to-detector distance. This test serves to ensure the correct inverse square behavior 
is obeyed.
Test field D checks the component of output dominated by the primary radiation source.(3) 
It relies on the measured output of a small (less than 3 cm × 3 cm) field. 
Test E is sensitive to the primary photon fluence and associated control system. In order to 
accomplish this evaluation, the two-dimensional dose distribution for a 20 cm × 20 cm field 
at a deep location (20 cm) is analyzed. In addition, discrete metrics for energy are assessed. 
The ratio of the central axis outputs at 20 cm and 10 cm depths forms one metric that is com-
parable conceptually to a test of tissue-to-phantom ratios at these two depths. The flatness at 
a clinically relevant depth is used as an additional check of energy, as justified by the work of 
Gao et al.(7)
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Test F is designed to be sensitive to extrafocal photon and electron fluences and the associ-
ated control system. The two-dimensional dose distribution at a shallow depth (depth of dose 
maximum or less) for a large field is evaluated.(2,8) This test is performed at a reduced SSD, 
which enables the validation of fluence across the largest possible field size.
Test G measures the collimator exchange effect, which is sensitive to extrafocal photon 
components (e.g. linac head scatter).(9,10) The exchange effect is tested using the ratio of the 
output factors for two long, narrow fields with the length greater than five times the width. 
Test H measures output linearity which evaluates the control system.(2) The output for a 
representative field is measured for 5, 50, and 200 monitor units.
Test I assesses the impact of changes in dose rate which evaluates the control system. The 
output is measured at the highest and lowest available dose rates.
Test J measures changes in output as a function of gantry angle.(2) The output at the four 
cardinal gantry angles is assessed for a standard field size.
Test K assesses multiple factors using a 1 cm wide MLC-shaped slit that is delivered using 
dynamic IMRT delivery.(11) A reference dose value is collected along the central axis and the 
acquired cross-plane profile is compared to the baseline. For this test, changes in MLC calibra-
tion can impact the effective dosimetric leaf gap and change the results; therefore, a favorable 
comparison to baseline must be evaluated in combination with all other test results.
B.   Setting up the test fields 
The MatriXX Evolution from IBA Dosimetry (Bartlett, TN), a 32 × 32 array of 4.5 mm diameter 
ion chambers spaced on 7.62 mm centers over a field size of 24 cm × 24 cm, was selected as 
the 2D measurement array for this project. This device was already in use by our clinic and its 
performance was characterized and understood by our physics staff.  The instrument incorporates 
automatic temperature and pressure corrections. The interface to the MatriXX device uses the 
MatriXX IMRT software version 1.7b (IBA Dosimetry). This software acquires the raw charge 
values from the 1020 ion chambers, applies corrections and calibrations to the data, and can be 
used to determine a number of key metrics including the calibration correction factor (kuser), 
dose values for measured locations (Gy), flatness (%), symmetry (%), and penumbra (mm).  
The ionization chamber locations, size, buildup, and backscatter were considered when 
designing the field dimensions and setup conditions for each constancy test. Plastic Water 
(Gammex Inc, Middleton, WI) was used both as buildup and backscatter material. Table 1 
describes field specifics and setup conditions for each constancy test, the data collected, and the 
comparisons performed. Jaws were used to shape the fields, with the exception of the swept field 
test. Each field was delivered at a dose rate of 600 MU/min and for a total of 200 MUs, unless 
indicated in the table. The specified buildup is in addition to the inherent buildup (3.2 mm) in 
the MatriXX device. The fields were ordered as indicated in the field label column to minimize 
the number of changes in buildup and SDD (source-to-detector plane distance). In some cases, 
it was possible to use the same fields to investigate two properties, such as the use of field 10 
to test both the collimator exchange effect and X penumbra. Reference values for the metrics, 
indicated in the final column with a subscript “ref,” indicate the baseline values that the col-
lected data are compared against. The methods of determining these baselines are described in 
the Materials & Methods section (D) below. In addition to the metrics listed in the table, the 
planar doses from each field are saved and available for further analysis and investigation.
Table 1 was designed to efficiently convey the specifics of each test field in order to enable 
the reader to replicate them. Some of the more unfamiliar metrics and terms require further 
explanation. 
The first field, F1, uses the calibration correction factor kuser to assess the output constancy 
of the machine. The kuser value is utilized by the software to scale the temperature and pressure 
corrected raw chamber readings and to provide a readout in absolute dose. In this role it mim-
ics an ion chamber calibration factor, only the user is able to acquire the calibration factor by 
delivering a known dose to the device. kuser is determined in the software as the known dose 
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Table 1. A description of the specific field parameters and metrics for each constancy test. SDD refers to the source-
to-detector (plane) distance. The buildup is in addition to the inherent 3.2 mm buildup in the device.
   Independent
   Jaw Plastic  Gantry /
   Positions Water  Collimator Data
 Field Test X1, X2 Build up SDD Angles Collected
 (s) (s) Y1, Y2 (cm) (cm) (degrees)  (Metric) Comparison(s) Performed
 F1 A 5,5 5 100 0/0 kuser 1/kuser to 1/kuser,ref
   5,5     Gycax(F1)
a 
 F2, F3,  J 5,5 5 100 270/0 Gycax(F2) Gycax(F2) to Gycax(F2)ref
 F4  5,5   90/0 Gycax (F3)  Gycax(F3) to Gycax(F3)ref
      180/0 Gycax (F4) Gycax(F4) to Gycax(F4)ref
 F5, F6 H 5,5 5 100 0/0 Gycax(F5) Gycax(F5) to Gycax(F5)ref
   5,5    @5 MUs Gycax(F6) to Gycax(F6)ref
       and
       Gycax(F6) 
       @50 MUs 
 
 F7 I 5,5 5 100 0/0 Gycax(F7) Gycax(F7) to Gycax(F7)ref
   5,5    @ 100
       MU/min
       dose rate 
 F8 K 6,6 5 100 0/0 Profile @ Gycax(F8) to Gycax(F8)ref
   12,12    400MUs, X profile comparison
   (Swept 1cm    Gycax(F8) to reference
   MLC Gap) 
 F9 D 0.6, 1.4 5 100 0/0 Gy(F9)b Gy(F9) to Gy(F9)ref
   0.6, 1.4 
 
 F10 B 2.3, 2.3 10 100 0/3.8 X jaw Xpenc to Xpenref
   12.5, 12.5    penumbra
 
 F10 G 2.3, 2.3 10 100 0/3.8 Gycax(F10) [Gycax(F10) / Gycax(F11)] to
   12.5, 12.5      [Gycax(F10) / Gycax(F11)] ref
 F11 B 12.5,12.5 10 100 0/3.8 Y jaw  Ypen  to Ypenref
   2.3,2.3    penumbra
 F11 G 12.5,12.5 10 100 0/3.8 Gycax(F11) [Gycax(F10) / Gycax(F11)] to
   2.3,2.3      [Gycax(F10) / Gycax(F11)] ref
 F12 E 10,10 10 100 0/0 Flatness Flatness(F12) to Flatness(F12)ref
   10,10    Symmetry Symmetry(F12) to Symmetry(F12)ref
       Gycax(F12) Gycax(F12) to Gycax(F12)ref
 F13 E 10,10 20 100 0/0 Gycax(F13) [Gycax(F13)/ Gycax(F12)] to
   10,10    Planar dose [Gycax(F13)/ Gycax(F12)]ref
        Planar dose difference relative to
        planar F13ref
        Profiles relative to F13ref
 F14 C 16,16 1 75 0/0 Gycax(F14)  Gycax(F14) to Gycax(F14) ref
   16,16
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divided by the average raw values for the four middle chambers of the array.(12) These four 
chambers, centered around the central axis of the beam, provide an average output over an area 
of approximately 1.2 cm × 1.2 cm surrounding the CAX. For the first test (A), the kuser factor is 
used in a reverse role, where the constancy of the calibration factor is used to assess the dose. 
If the raw chamber responses are precise, then the acquired value of 1/kuser can be compared to 
the reference value and used as an indicator of whether the beam output calibration is constant. 
Validation that kuser can be used in this role is required.
Fields F2, F3, and F4 assess output constancy as a function of gantry angle. The outputs of 
the central axis chamber are recorded for gantry angles of 90°, 180°, and 270°. Since a number 
of comparisons to baseline are performed at a gantry angle of 0°, there is no need to perform 
an additional constancy check at this angle.  
Fields F5 and F6 assess the output constancy for fields delivering 5 MUs and 50 MUs, 
respectively. When combined with the other fields delivering 200 and up to 400 MUs, the 
output over a range of clinically significant MUs is validated.
Field F7 assesses the constancy of the output delivered at the lowest clinically available 
dose rate. Since the other tests use a dose rate of 600 MU/min the goals of Test I are met with 
the addition of this one field.
Field F8 uses the dynamic delivery of a sliding 1 cm gap formed by the leaves of the MLC. 
Central axis output and transverse (X) profiles are compared to baseline.
Field F9 uses a 2 cm × 2 cm field centered on a single MatriXX chamber. The output reported 
by this chamber is compared to the baseline value. A 2 cm × 2 cm field was selected as a com-
promise size. The smaller the field, the more small changes in jaw calibration and alignment 
will cause fluctuations in output, while the larger the field, the more extrafocal radiation comes 
into play.
Fields F10 and F11 are used to assess the collimator exchange effect, as well as the X and 
Y jaw penumbras. The collimator exchange effect is determined using the central axis output 
measured for each of these long, narrow fields. The penumbra values reported by the OmniPro 
IMRT software (Iba Dosimetry) are used to quickly assess penumbra constancy. This value is 
displayed in the active window of the software when the profile cursor is placed along the field 
edge. The penumbra is defined in the software as the distance between the 80% and 20% points 
along the edge of the beam.(12) Given the detector size and spacing, the results were expected to 
be highly dependent on the positions of the jaws relative to the row of detectors on either side 
of the field edge. Experimentally this was found to be the case. Deconvolution could be used to 
determine an absolute penumbra but would require export of the data and a second analytical 
method, both time-consuming steps. One method of removing this jaw position dependency 
would be to always place the jaw edge at the same exact position relative to the detectors, an 
intractable solution. Instead, these long fields (and therefore jaw edges) were used in combination 
Table 1. (cont’d.)
   Independent
   Jaw Plastic  Gantry /
   Positions Water  Collimator Data
 Field Test X1, X2 Build up SDD Angles Collected
 (s) (s) Y1, Y2 (cm) (cm) (degrees)  (Metric) Comparison(s) Performed
 F14 F 16,16 1 75 0/0 Planar Planar dose difference relative
   16,16     dose  reference for F14
        Profiles relative reference for F14
        Flatness(F14) to Flatness(F14)ref
        Symmetry(F14) to Symmetry(F14)ref
a Nomenclature: Reported value in Gy for the central axis chamber, test field F1.
b The reading in Gy from the off-axis chamber at the center of the small field F9.
c Pen refers to “penumbra” as reported by the Matrixx software.
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with a slight collimator rotation. This created a long line of adjacent detector pairs that straddle 
each jaw edge, with the collimator rotation ensuring that the centering of the jaw edge between 
detectors was slightly different along the length. The profile cursor location was then “scanned” 
over the central 20% of the jaw edge to find the local minimum penumbra as reported by the 
software. This step took only seconds and was intended to reduce the sensitivity to changes in 
setup. Validation that this technique is repeatable and viable is required.
Fields F12 and F13 are used as comprehensive checks of energy, as described above for 
Test E. Central axis output, flatness, and symmetry are assessed, while profile and planar dose 
comparisons to baseline are also performed. Flatness and symmetry are automatically deter-
mined over the central 80% of the field width by the software. Flatness is calculated using the 
relationship:
 100 × (Dmax-Dmin)/(Dmax+Dmin) (1)
Dmax is the maximum dose measured along the central 80% of the profile, while Dmin is the 
minimum dose over the same region. Symmetry is the maximum difference between the two 
points equidistant (left and right) from the central axis.  
Field F14 is a large field delivered at a reduced SSD. Once again central axis output, flatness, 
and symmetry are determined, and profiles, as well as planar dose comparisons to baseline, 
are performed.  
C.   Data collection
The Varian TrueBeam used for the experiments is configured with the standard 120 leaf multileaf 
collimator (MLC), a maximum field size of 40 cm × 40 cm, and the Exact IGRT couch. The 
6 MV energy was used for all tests. Before initiating each data collection session, the position-
ing lasers were verified as accurate to within 1 mm. Two 4 cm thick slabs of plastic water, each 
piece labeled with a letter and orientation marker, were centered on the couch with the superior 
edge flush with the couch end. The MatriXX device was carefully centered on this plastic water 
under the central axis (CAX) of the accelerator with the detector plane set to 100 cm from the 
source. The detector array was then aligned to the radiation field central axis using an in-house 
method. Marks were placed on the solid water at the first data collection to ensure repeatable 
positioning for subsequent experiments. Data collection was initiated with 5 cm of plastic water 
centered on top of the MatriXX. As additional slabs were needed, they were always added in 
the same order and orientation, ensuring that the exact same buildup piece was used in the exact 
same location from experiment to experiment. Changes in source-to-detector distance were 
accomplished by changing the vertical couch position the required amount, then verifying the 
shift against the lateral lasers using a steel machinist’s rule.
All fields were incorporated into a single plan in the Aria Record and Verify system (Varian 
Medical Systems). Fields were delivered in QA mode, and data as indicated in Table 2 were 
collected. The raw data for each acquired field (except for F9, the small field output) were 
converted to a 0.2 cm grid size along one center line, as described in the OmniPro IMRT 1.7b 
manual. This conversion effectively up-sampled the data, with the midpoint of the central pixel 
placed exactly in the center of the array. For field F9, the raw measured dose for the single 
chamber at the center of the field was used. 
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D.  Setting baselines
Five repeat measurements of the test suite were acquired to set baseline values of all measured 
parameters. In order to capture realistic variations in results, these measurements were accom-
plished over a period of six weeks by two different individuals. The mean and standard deviation 
of the results were calculated and used to determine target values, as well as upper and lower 
investigation levels. Prior to any data collection, it was anticipated that investigation levels 
would be set to ± 3 SDs to minimize false-positives (false test failures). For experiments that 
obey a normal distribution and behave as expected, 99.7% of all results should fall within these 
limits. This goal can be revisited if the standard deviation is so large that the investigational 
levels fall significantly outside the comparable TG-142 recommendations. One of the acquired 
datasets was also identified as the reference dataset, the standard used to perform future profile 
and planar dose comparisons. The dataset with the smallest deviation between the measured 
and mean kuser was selected for this purpose.
E.   Method validation
The utility of an ionization chamber array for assessing photon energy, relative dose, flatness, 
and symmetry is well established in prior publications.(13,7) The effect of MLC position on 
ionization chamber output for a dynamic IMRT field has also been previously reported.(11) 
Verification that profiles are adequately represented by the array is a prudent step. The ability 
to detect meaningful changes in focal spot characteristics (through the surrogate of penumbra) 
and absolute dose calibration (through the surrogate of kuser) requires validation. Verification 
that changes in beam energy are detectable was also performed.  In order to test the sensitivity 
of the method, a different linear accelerator with slightly different beam characteristics was 
also tested. Use of the method over a period of nine months assessed whether false positives 
could be expected due to small setup variations or drifts in array response. 
Profiles for 20 cm × 20 cm fields were acquired with both the Welhoffer Blue scanning 
water phantom (IBA Dosimetry) and the MatriXX device underneath plastic water. The Blue 
Table 2. The results of the constancy tests showing the average and standard deviation for each metric, as well as the 
upper investigation level (UIL) and lower investigation level (LIL) adopted for each measurement group. 
 Metric Avg St Deva UILa LILa
 1/kuser,ref 1.317 rdg/cGy 0.56% +1.7% -1.7%
 Gycax(F2)ref 128.9 cGy 0.12% +0.81% -0.81%
 Gycax(F3)ref 127.6 cGy 0.17% +0.81% -0.81%
 Gycax(F4)ref 136.0 cGy 0.13% +0.81% -0.81%
 Gycax(F5)ref 4.70 cGy 0% +0.81% -0.81%
 Gycax(F6)ref 47.48 cGy 0.27% +0.81% -0.81%
 Gycax(F7)ref 189.7 cGy 0.16% +0.81% -0.81%
 Gycax(F8)ref 36.30 cGy 0.19% +0.81% -0.81%
 Gy(F9)ref 159.1 cGy 0.18% +0.81% -0.81%
 Gycax(F14)ref 400.2 cGy 0.25% +0.81% -0.81%
 [Gycax(F10) / Gycax(F11)] ref 1.013 0.13% +0.40% -0.40%
 [Gycax(F13)/ Gycax(F12)]ref 0.7055 0.09% +0.40% -0.40%
 Xpenref 0.741 cm 0.30% +1.1% -1.1%
 Ypenref 0.767 cm 0.36% +1.1% -1.1%
 Xflatness(F12)ref 2.10% 0.01% (abs) +0.45% (abs) -0.45% (abs)
 Yflatness(F12)ref 2.36% 0.04% (abs) +0.45% (abs) -0.45% (abs)
 Xsymmetry(F12)ref 0.22% 0.04% (abs) +0.45% (abs) -
 Ysymmetry(F12)ref 0.71% 0.11% (abs) +0.45% (abs) -
 Xflatness(F14)ref 1.75% 0.03% (abs) +0.45% (abs) -0.45% (abs)
 Yflatness(F14)ref 1.64% 0.03% (abs) +0.45% (abs) -0.45% (abs)
 Xsymmetry(F14)ref 0.19% 0.03% (abs) +0.45% (abs) -
 Ysymmetry(F14)ref 0.56% 0.15% (abs) +0.45% (abs) -
a % means the number is normalized to the average for the metric, while %(abs) is used for metrics which are already 
in percent and use an absolute change in percent for the limit.
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phantom was used in combination with CC13 primary and reference ionization chambers, also 
from IBA Dosimetry. Profiles were obtained at depths of 5 cm and 20 cm and at a 100 cm SSD. 
As explained in section B above, the X and Y jaw penumbra values reported by the OmniPro 
IMRT software for long narrow fields were used to verify penumbra constancy. Tests were 
accomplished to demonstrate that these reported penumbra results were invariant to jaw position 
and repeatable. Jaw edges were deliberately shifted from nominal by 2, 1, -1, and -2 mm and the 
penumbra was measured. A second validation test was used to determine if subtle changes in 
penumbra could be detected. The known change in penumbra with depth was exploited for this 
test. Penumbra values were measured at depths of 5 cm, 10 cm, 20 cm, and 30 cm in water, using 
the Wellhofer scanning water phantom described above. Plastic water was then used to achieve 
the same depth in the MatriXX and changes in penumbra were compared to the scan results.
The ability to detect small changes in output through the surrogate of kuser was validated 
using manual adjustment of the monitor units (MUs) for a reference 10 cm × 10 cm field. This 
adjustment of the MUs mimicked a machine calibration error over a range of +10% to -10%. 
The results were plotted against the inverse of kuser, since kuser itself is a correction factor.
A validation experiment tested the impact of changes in photon beam energy. An increase 
in mean effective energy was accomplished by adding a 6 mm thick (nominal thickness) layer 
of lead to the beam central axis (CAX) on the accessory tray. This lead covered the entire field 
and served to harden the beam, but at the same time it also perturbed the photon fluence and 
generated secondary photons and electrons. Other more realistic methods of simulating changes 
in energy and fluence were also considered, but they involved altering the accelerator settings. 
Since the accelerator was in heavy clinical use, these methods were abandoned in favor of the 
“noninvasive” use of a beam hardening layer. This experiment was only judged to be useful as 
a way of validating the use of the ratio of two outputs, at 20 cm and 10 cm depths, as a simple 
discriminator for energy.  The change that resulted from the addition of the lead layer was first 
characterized using a scanning water phantom and an Exradin A12 chamber (Standard Imaging, 
Middleton, WI). The ratio of the measured percent depth doses at 10 cm (PDD10) and 20 cm 
(PDD20) depths for both the standard and hardened beam was measured using a 10 cm × 10 cm 
field. Test fields F12 and F13 were then delivered and measured on the MatriXX using the setup 
described above, and the ratio Gycax(F13)/ Gycax(F12) was determined.  
A second linear accelerator, a Varian 21EX (Varian Medical Systems), is also in use in 
our department. The head design of this accelerator is similar to the TrueBeam, but there are 
subtle differences. For example, the ion chamber assembly on the TrueBeam machine is actu-
ated to move when the light field is activated, and there is an antibackscatter filter in the head 
of the TrueBeam. The properties of the 21EX 6 MV beam are nearly identical to those of the 
TrueBeam 6 MV beam used for this study, and the machines are calibrated to have identical 
absolute outputs. The measured percent depth dose at a 10 cm depth for a 10 × 10 field was 
66.2% for the 21EX and 66.3% for the TrueBeam. Other beam properties were compared and 
found to be within 1% for all but the smallest field sizes, a result consistent with the findings 
of Beyer.(14) Water phantom scan comparisons of this machine and the TrueBeam  indicate 
that they are matched to within TG-142 tolerances. The suite of tests was run on this alternate 
machine in order to assess the sensitivity of the method. If the detector array technique is suf-
ficiently sensitive, the subtle differences between the two beams should trigger findings outside 
the investigation levels.
The test set was run numerous times over a period of nine months following minor repairs 
and adjustments. The machine underwent beam steering and tuning, jaw calibrations, two 
output calibration changes of 1% or less, and an ion chamber position calibration during this 
period. All of the repairs were confirmed by traditional measurements. The MatriXX test suite 
was then run with the purpose of identifying whether false-failures were triggered, indicating 
that the investigation levels were too tight to be clinically useful.
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III. RESULTS & DISCUSSION 
Each acquisition of the baseline data took approximately 15 min to set up and no more than 
30 min to run once the method was developed. Table 2 displays the results. Upper and lower 
investigation levels (UILs and LILs, respectively) for each parameter were initially set based 
on three times the largest observed standard deviation within each of the five logical mea-
surement “families” of 1/kuser, penumbra, measured dose (in Gy), flatness and symmetry, and 
ratios of Gy. It is noted that, for practical reasons, the lower investigation level for symmetry 
will always be 0%. All of the resultant criteria were significantly tighter than the comparable 
TG-142 recommended tolerances for monthly or annual testing, with the exception of 1/kuser (the 
analog of output), which was within the monthly recommended level of 2% but exceeded the 
recommended annual output calibration tolerance of 1%. The very tight investigational levels 
reflect the advanced digital control capabilities of TrueBeam and demonstrate the benefit of 
customizing tolerances when possible. The more strict criteria compared to the TG-142 values 
make the test suite an effective early warning system for beam property drifts. 
The third dataset was identified as the reference and used for profile and planar dose com-
parisons. The investigation levels for dose (± 0.81%) were also used as thresholds for the 
planar dose difference comparisons which were performed over the central 80% of each field. 
Comparisons between experiments performed weeks apart by different individuals revealed 
almost identical profiles that were virtually superimposed when plotted simultaneously. It is 
noted that, although the comparison of dose planes can provide additional information, profile 
comparisons were found to be a more practical way of evaluating results.
Comparisons of two profiles measured with the MatriXX and with the scanning water phan-
tom are shown in Fig. 1. Results show a reasonable level of agreement. Since the MatriXX 
test suite relies on comparisons to baseline measurements acquired on the same array device, 
it is not critical that the water tank and MatriXX profiles show perfect agreement. Unexpected 
differences in the magnitude of the horns, misshapen profiles, or severe discontinuities not 
explained by sampling considerations would warrant further investigation. None were noted. 
The penumbra repeatability tests demonstrated a standard deviation of 0.6% over the entire 
range of jaw positions tested, indicating that using a slight collimator rotation is effective 
compensation for test-to-test variations in jaw position. Figure 2 shows a plot of the penumbra 
Fig. 1. Cross-plane profiles acquired using a scanning water phantom and the MatriXX. The setup SSD was 100 cm and 
profiles were acquired at depths of 5 cm and 20 cm. The lateral extent of the area covered by the ionization chambers in 
the MatriXX is ± 12 cm.   
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measured with the MatriXX against the penumbra measured with the CC13 ion chamber. An 
R2 value of 0.9995 was calculated for the trend line, indicating a nearly linear relationship. 
Although the penumbra reported by the OmniPro IMRT software is not a true penumbra, these 
two results indicate that it serves as a reasonable and quick measure of penumbra constancy. 
For a more accurate measure of absolute penumbra, the ion chamber readings could be decon-
volved with detector size.(15)
Figure 3 displays the plot of 1/kuser against the change in monitor units that mimicked a 
machine calibration error. The response is nearly linear. Changes in 1/kuser, therefore, appear 
to be an appropriate surrogate for changes in machine output.
The scanning water phantom tests demonstrated that the addition of lead to the 6 MV beam 
resulted in a PDD20/PDD10 ratio of 0.587, a 2.3% increase over the value of 0.574 observed for 
the unhardened beam. The energy change represents a subtle, but clinically significant, shift that 
should be easily identified by the metric GyCAX(F13)/GyCAX(F12). The measured GyCAX(F13)/
GyCAX(F12), which is effectively a TPR20/TPR10 ratio, increased by 2.5% to 0.723 with the 
addition of the lead layer and was well outside the UIL of 0.708.  It is noted that profiles were 
also significantly altered by the lead layer, but the results are not reported because the findings 
could not be definitively attributed solely to the change in energy.    
Fig. 2. The penumbra reported using the proposed MatriXX-based method plotted against the same penumbra measured 
using a scanning ionization chamber.    
Fig. 3. A plot of 1/kuser vs. the delivered monitor units. The MatriXX kuser factor was deliberately acquired using the incor-
rect number of MUs to mimic a machine calibration error. A nearly linear response to the change in MUs is displayed. 
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The results of the 21EX comparison are summarized in Table 3.  Profiles and planes appeared 
nearly identical, but ten of 22 metrics were outside the set investigation levels. Although none 
of the discrepancies were large, the test suite was sensitive to subtle machine-to-machine 
variations. Three notable differences stand out. The ratio Gycax(F10) / Gycax(F11) ref is a test 
designed to be sensitive to the collimator exchange effect. The 21EX result for this metric was 
approximately 1% higher than the average value reported for the TrueBeam machine. As noted 
earlier, the monitor chamber is mounted using a different arrangement on the TrueBeam and 
there is an antibackscatter filter in place. A change in the amount of backscatter into the monitor 
chamber from the upper jaw could easily account for the measured deviation. The output for 
field F9 shows a lower value for the 21EX compared to the TrueBeam, pointing to a difference 
in small field output factors and, possibly, primary focal spot characteristics. The difference 
in the output for field F8 is likely the result of a number of factors, with the dissimilarity in 
dosimetric leaf gap offset between the two machines (1.2 mm vs. 1.8 mm) a major contributor.
The investigation levels for the proposed method are, in general, significantly tighter than 
the values used in the report of AAPM Task Group 142.(2) Concern over unnecessary triggers 
of these levels is, therefore, warranted. Repeat use of the test suite over a period of nine months 
alleviated these concerns. The experiments were run five times by two different individuals 
and at different times of the day following machine repairs or adjustments. No failures were 
noted after any of the minor repairs described above, except for one finding that was margin-
ally outside the investigation level for field F3. This finding was attributed to a slight setup 
discrepancy, and a repeat measurement confirmed that suspicion. A modest increase in the 
investigation level for the output metrics, to ± 1% instead of the ± 0.81%, could be used to 
further limit unwarranted failures.
In order for this constancy testing to be effective, it is imperative that the performance of the 
MatriXX be constant over time. IMRT QA experience with the MatriXX device over several 
years demonstrates this to be the case. User uniformity calibrations can be periodically used to 
homogenize the response of the chambers, if needed.
Table  3. The results, other than plane and profile comparisons, of tests performed on a different machine (21EX) 
with almost identical beam properties. The reference average, upper investigation level, and lower investigation level 
for each metric are compared to the results obtained for the 21EX. Measured values falling outside the bounds set by 
the UIL and LIL are labeled as a fail or “F” in column 6.
  Reference   21EX Pass (P) or
 Metric Avg. UIL LIL Result Fail (F)
 1/kuser,ref 1.317 rdg/cGy 1.340 rdg/cGy  1.295 rdg/cGy  1.311 rdg/cGy  P
 Gycax(F2)ref 128.9 cGy 130.0 cGy 127.9 cGy 130.6 cGy F
 Gycax(F3)ref 127.6 cGy 128.6 cGy 126.6 cGy 128 cGy P
 Gycax(F4)ref 136.0 cGy 137.1 cGy 134.9 cGy 139.3 cGy F
 Gycax(F5)ref 4.70 cGy 4.74 cGy 4.66 cGy 4.8 cGy F
 Gycax(F6)ref 47.48 cGy 47.87 cGy 47.10 cGy 47.4 cGy P
 Gycax(F7)ref 189.7 cGy 191.2 cGy 188.2 cGy 190.9 cGy P
 Gycax(F8)ref 36.30 cGy 36.59 cGy 36.00 cGy 39.0 cGy F
 Gy(F9)ref 159.1 cGy 160.4 cGy 157.9 cGy 156.7 cGy F
 [Gycax(F10) / Gycax(F11)] ref 1.013 1.017 1.009 1.0234 F
 Xpenref 0.741 cm 0.749 cm 0.733 cm 0.735 cm P
 Ypenref 0.767 cm 0.775 cm 0.759 cm 0.74 cm F
 Xflatness(F12)ref 2.10% 2.55% 1.65% 2.37% P
 Yflatness(F12)ref 2.36% 2.81% 1.91% 2.34% P
 Xsymmetry(F12)ref 0.22% 0.67% - 0.93% F
 Ysymmetry(F12)ref 0.71% 1.16% - 0.57% P
 [Gycax(F13)/ Gycax(F12)]ref 0.7055 0.708 0.703 0.7071 P
 Gycax(F14)ref 400.2 cGy 403.4 cGy 396.9 cGy 401.4 cGy P
 Xflatness(F14)ref 1.75% 2.2% 1.3% 2.23% F
 Yflatness(F14)ref 1.64% 2.09% 1.19% 2.04% P
 Xsymmetry(F14)ref 0.19% 0.64% - 0.91% F
 Ysymmetry(F14)ref 0.56% 1.01% - 0.53% P
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If this test suite is used in a clinical scenario it will be used in combination with other QC 
tests. Vendor recommended and TG-142–required QA testing would always be performed.(2) 
Standard daily QA, always performed by the therapists before treatments are delivered, would 
further validate output. A reference plan from a highly modulated VMAT reference case, or a 
highly modulated reference IMRT field, could also be tested to validate the delivery of these 
special modalities.
Most diode or chamber arrays could be used to develop a similar method of machine vali-
dation; in fact, a diode array will likely offer a detector size advantage, at a possible cost of 
additional device calibration measurements. The smaller detector could enable the use of a 
much smaller reference field for the small field test (test D), further isolating the contribution of 
the primary radiation source. Almost any detector array would offer a considerable savings of 
time and complexity compared to setting up a water phantom, although water phantom testing 
would still be required following major repairs. It is the experience of the authors that setting 
up a scanning water phantom, performing measurements over a range of setup conditions, and 
accomplishing meaningful comparisons to baseline values takes more than an 8-hour day. In 
contrast, the setup described herein takes approximately 1.5 hrs to acquire the data and perform 
meaningful analysis for two photon energies.  
Future work could involve extending this method to flattening filter-free photon beams and 
electrons, and performing additional validation experiments using a “test only” accelerator. 
Deliberate variations in energy, focal spot size, and other parameters could be introduced to 
such an accelerator without concern for the potential clinical impact. 
 
IV. CONCLUSIONS
A simple construct for the radiation contributions from a linear accelerator head was used to 
develop a test suite capable of efficiently assessing the constancy of beam properties using an 
ionization chamber array. The suite demonstrated upper and lower investigation levels less than 
or equal to the comparable TG-142 recommended annual tolerance values for all properties 
other than beam output, where a slightly larger but still acceptable investigation level (within 
the recommended monthly tolerance) was identified. Clinically significant changes in output, 
beam penumbra, and beam energy were easily detected with this method. This method may be 
useful for validating beam properties after a minor repair, performing periodic validations of 
linear accelerator performance constancy (quarterly or semi-annually), and identifying drifts 
in machine performance. It may also find application as an adjunct to annual water phantom 
scanning, since the tight investigation levels used in this method may aid in identifying where 
a more detailed analysis of the scanning results should be directed.  
 
REFERENCES
 1.  Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology. Report of AAPM Radiation 
Therapy Committee Task Group 40. Med Phys. 1994;21(4):581–618.
 2.  Klein EE, Hanley J, Bayouth J, et al. Task Group 142 Report: quality assurance of medical accelerators. Med 
Phys. 2009;36(9):4197–212. 
 3.  Chetty IJ, Curran B, Cygler JE, et al. Report of the AAPM Task Group No. 105: issues associated with clinical 
implementation of Monte Carlo-based photon and electron external beam treatment planning [Electronic version]. 
Med Phys. 2007;34(12):4818–53. 
 4.  Fippel M, Haryanto F, Dohm O, Nüsslin F, Kriesen S. A virtual photon energy fluence model for Monte Carlo 
dose calculation [Electronic version]. Med Phys. 2003;30(3):301–11.
 5.  Sham E, Seuntjens J, Devic S, Podgorsak EB. Influence of focal spot on characteristics of very small diameter 
radiosurgical beams [Electronic version]. Med Phys. 2008;35(7):3317–30. 
 6.  Wang LLW and Leszczynski K. Estimation of the focal spot size and shape for a medical linear accelerator by 
Monte Carlo simulation [Electronic version]. Med Phys. 2007;34(2):485–88. 
58  Ritter et al.: 2D array for linac evaluation 58
Journal of Applied Clinical Medical Physics, Vol. 15, No. 6, 2014
 7.  Gao S, Balter P, Rose M, Simon WE. Measurement of changes in linear accelerator photon energy through flat-
ness variation using an ion chamber array [Electronic version].  Med Phys. 2013;40(4):042101.
 8.  Lopez Medina A, Teijeiro A, Garcia J, et al. Characterization of electron contamination in megavoltage photon 
beams [Electronic version]. Med Phys. 2005;32(5):1281–92. 
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